Maria Popova

SANOCHEMIA Pharmazeutika GMBH engages in the manufacture and distribution of pharmaceutical products. It operates through the following segments: Production, Human Pharmaceuticals, Veterinary Pharmaceuticals, Research and Development, and Others. The Production segment focuses on the synthesis of active pharmaceutical substances, drug formulation and pharmaceutical production. The Human Pharmaceuticals segment comprises of diagnostic activities including products such as X-ray and magnetic resonance imaging agents. The Veterinary Pharmaceuticals segment involves in veterinary medicine production, administration, and drug development. The Research and Development segment implements clinical trials and acquires licenses for the drugs. The company was founded by Werner Josef Frantsits on November 13, 1990 and is headquartered in Vienna, Austria.

Part of SANOCHEMIA Pharmazeutika GmbH, Sanochemia UK Ltd. manufactures pharmaceutical products. The company is based in Bristol, UK. Sanochemia was acquired by SANOCHEMIA Pharmazeutika GmbH on September 30, 2009. The CEO of the British company is Maria Popova.